http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 11 Jun 2026 13:50:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++3++++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01++Filed+by%3A+Sandor+Victor/26634923.html si-local-file:///var/storage/secattach/20260611/26634923.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01++Filed+by%3A+Sandor+Victor/26634923.html Thu, 11 Jun 2026 13:50:00 -0400 ABCL O.49308943 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01++Filed+by%3A+Sandor+Victor/26634923.html si-local-file:///var/storage/secattach/20260611/26634923.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01++Filed+by%3A+Sandor+Victor/26634923.html Thu, 11 Jun 2026 13:50:00 -0400 ABCL O.49308943 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01/26609833.html si-local-file:///var/storage/secattach/20260605/26609833.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01/26609833.html Fri, 05 Jun 2026 12:04:00 -0400 ABCL O.49308943 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01/26609833.html si-local-file:///var/storage/secattach/20260605/26609833.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AbCellera+Biologics+Inc.++For%3A+Jun+01/26609833.html Fri, 05 Jun 2026 12:04:00 -0400 ABCL O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html <p>AbCellera Biologics Inc. (NASDAQ: ABCL) announced the appointment of Dr. Victor Sandor as an independent director to its board of directors.</p> <p>Dr. Sandor previously served as Chief Medical Officer at Array BioPharma Inc. before its acquisition by Pfizer Inc., where he secured approval of Braftovi and Mektovi. He also held the position of Senior Vice President for Global Clinical Development at Incyte Corporation, contributing to the approval of Jakafi.</p> <p>His career includes roles as Vice President and Chief Medical Officer for Oncology at Biogen Inc. and positions at AstraZeneca Pharmaceuticals LP, where he contributed to the registration of Arimidex and development of http://www.streetinsider.com/Board+Changes/AbCellera+appoints+Dr.+Victor+Sandor+to+board+of+directors/26608855.html Fri, 05 Jun 2026 09:00:38 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943 http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html <p> VANCOUVER, British Columbia--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.abcellera.com&amp;esheet=54547091&amp;newsitemid=20260605492754&amp;lan=en-US&amp;anchor=AbCellera&amp;index=1&amp;md5=8015fd3fb63f86841acfeae65f314c94" shape="rect">AbCellera</a> (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. </p><p> “Dr. Sandor is an experienced director and a distinguished medical oncologist with experience in building companies and bringing innovative medicines to patients in need,” said Carl Hansen, Ph.D., founder and CEO of AbCellera. “I am pleased to welcome Dr. Sandor to AbCellera’s Board of Directors and look forward to working with him.” </p><p> Before its acquisition by Pfizer Inc., Dr. Sandor served as Chief Medical Officer at Array BioPharma Inc. where he http://www.streetinsider.com/Press+Releases/AbCellera+Appoints+Dr.+Victor+Sandor+to+its+Board+of+Directors/26608823.html Fri, 05 Jun 2026 09:00:00 -0400 A.09091570 A.19655944 A.27792256 A.33353809 A.50114084 ABCL O.00002198 O.00179799 O.01668149 O.03307993 O.19718576 O.49308943